-
Purposeexpresses eGFP from a 400 bp human FOXA2 promoter to select floor plate and ventral midbrain progenitor cells during development
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 59404 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepRRL.cPPT.PGK-GFP.WPRE.Sin-18
-
Backbone manufacturerD. Trono, EPFL, Lausanne, CH
- Backbone size w/o insert (bp) 7272
- Total vector size (bp) 7668
-
Modifications to backbonereplaced pPGK promoter in pRRL.cPPT.PGK-GFP.WPRE.Sin-18 with 396 bp human 5' FOXA2 promoter region upstream of Exon 1 using 5' XhoI and 3' AgeI restriction sites. Ref.: Navas MA et al., 2000, Human Heredity 50:370-81.
-
Vector typeMammalian Expression, Lentiviral
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)Stbl3
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert name400 bp FOXA2 promoter, eGFP
-
Alt nameHNF3beta promoter
-
Alt nameForkhead box A2 promoter
-
Alt nameTCF-3B promoter
-
SpeciesH. sapiens (human)
-
Insert Size (bp)396
-
Entrez GeneFOXA2 (a.k.a. HNF-3-beta, HNF3B, TCF3B)
- Promoter pFOXA2
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site XhoI (not destroyed)
- 3′ cloning site AgeI (not destroyed)
- 5′ sequencing primer ggtacagtgcaggggaaag
- 3′ sequencing primer cagcttgccgtaggtggcatc (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
Lenti.pFOXA2.GFP was a gift from Kai-Christian Sonntag (Addgene plasmid # 59404 ; http://n2t.net/addgene:59404 ; RRID:Addgene_59404) -
For your References section:
Selection Based on FOXA2 Expression Is Not Sufficient to Enrich for Dopamine Neurons From Human Pluripotent Stem Cells. Aguila JC, Blak A, van Arensbergen J, Sousa A, Vazquez N, Aduriz A, Gayosso M, Paz Lopez Mato M, Lopez de Maturana R, Hedlund E, Sonntag K, Sanchez Pernaute R. Stem Cells Transl Med. 2014 Jul 14. pii: sctm.2014-0011. 10.5966/sctm.2014-0011 PubMed 25024431